LH
Labcorp Holdings Inc.
- Healthcare
- US companies in Healthcare (47)
- NYSE · USD
- Mkt cap $26.7bn
$328.95
as of 23 Oct 2026, 4% below its 52-week high
Screens as well placed to keep growing its dividend, with low cut-risk signals. Its valuation looks somewhat extended against its own history.
These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.
- Trailing yield
- 0.88%Last 12 months of regular payments at today's price
- Forward yield
- 0.88%Each payment expected in the next 12 months, not the latest one doubled
- Earnings cover
- 4.2×Pays 24% of earnings
- Cash cover
- 4.8×Free cash flow over dividends paid
- 5y dividend growth
- Not availableLast cut in FY2021
- Next ex-dividend date
- Declared24 Nov 2026Quarterly dividend of $0.72
Compared with US companies in Healthcare (47)
- Trailing yield is lower than 24 of the 46 other US companies in Healthcare.
Quality
83
HighCapacity to keep growing the dividend
Risk
0
LowSignals of dividend-cut pressure
Trim
67
ModerateHow extended the valuation looks
Why Trim is 67
LH against US companies in Healthcare (47)
Valuation against its own history
As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of LH’s past readings.
- P/E22.8×P64, neutral for this measure
- Yield1.03%P68, neutral for this measure
- FCF payout20.7%P78, poor for this measure
- Net debt / EBITDA3.08P42, neutral for this measure
- ROIC8.0%P78, good for this measure
Forecast your income with the LH dividend calculator
Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.